Detalles de la búsqueda
1.
Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease.
Hepatol Res;
53(3): 219-227, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36378589
2.
MRI-Based Quantitative R2* Mapping at 3 Tesla Reflects Hepatic Iron Overload and Pathogenesis in Nonalcoholic Fatty Liver Disease Patients.
J Magn Reson Imaging;
55(1): 111-125, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184822
3.
Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice.
J Pharmacol Sci;
147(2): 176-183, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34384565
4.
Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs.
Diagnostics (Basel);
10(11)2020 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171865
5.
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial.
Lancet Gastroenterol Hepatol;
5(11): 996-1007, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805205
6.
Metabolomic/lipidomic-based analysis of plasma to diagnose hepatocellular ballooning in patients with non-alcoholic fatty liver disease: A multicenter study.
Hepatol Res;
50(8): 955-965, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455496
7.
Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Hepatol Res;
49(10): 1136-1146, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144415
8.
Assessment of 10-year changes in liver stiffness using vibration-controlled transient elastography in non-alcoholic fatty liver disease.
Hepatol Res;
49(8): 872-880, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30974498
9.
Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.
J Gastroenterol Hepatol;
34(8): 1411-1416, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30506860
10.
Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.
Sci Rep;
8(1): 13567, 2018 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30206277
11.
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin.
Sci Rep;
8(1): 11365, 2018 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054551
12.
New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones.
J Gastroenterol Hepatol;
33(12): 2007-2014, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29851164
13.
Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
J Gastroenterol Hepatol;
33(12): 2022-2028, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29869419
14.
Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design.
Contemp Clin Trials;
69: 40-47, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29627620
15.
Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
J Gastroenterol Hepatol;
33(10): 1795-1803, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633352
16.
Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression.
Hepatol Res;
48(3): E320-E334, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29059699
17.
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study.
BMC Gastroenterol;
17(1): 96, 2017 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28789631
18.
Identification of core gene networks and hub genes associated with progression of non-alcoholic fatty liver disease by RNA sequencing.
Hepatol Res;
47(13): 1445-1458, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28219123
19.
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.
Sci Rep;
7: 42477, 2017 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28195199
20.
Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis.
Sci Rep;
6: 22251, 2016 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26911834